Schematic of the molecular mechanism underlying UA anticancer activity in NSCLC cells

A schematic of the molecular mechanism underlying UA anticancer activity in NSCLC cells. UA treatment inhibited the EGFR/JAK2/STAT3 signaling pathway, leading to the diminishment of Sox-2, Oct-4, ABCG2, CD133, and C-Myc.
Schematic of the molecular mechanism underlying UA anticancer activity in NSCLC cells

Publication

Inhibitory Effect and Mechanism of Ursolic Acid on Cisplatin-Induced Resistance and Stemness in Human Lung Cancer A549 Cells (2023) Luxin Fan, et al. Evid Based Complement Alternat Med. 2023;2023(NA). Figure: F8.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID